science
To sponsor this category, click here | subscribe to this category RSS

Home » Archives for science

Constellation banks $22M for ambitious epigenetics play

Wednesday, June 2nd, 2010

Constellation Pharmaceuticals

Read the full story

A checklist for drug company CEO’s

Monday, May 31st, 2010

1. All drugs in “the pipeline” have to have head to head clinical trials against current drugs on the market, especially generics, with a focus on patient outcomes.

Posted in: DTC | 0 Comments »
Read the full story

Tylenol Creator Dies As J&J Scandal Intensifies

Wednesday, May 26th, 2010

There is a sad irony here. Last Thursday, Robert McNeil, who concocted Tylenol back in 1955, passed away at age 94. After more than a half century of phenomenal success, his death occurred just as Johnson & Johnson became embroiled in a quality-control scandal over several recalls of dozens of products, most notably different forms of Tylenol (see background here and here )

Read the full story

NormOxys gets $17.5M to fund PoC work on new drug class

Monday, May 24th, 2010

Wellesley, MA-based NormOxys has wrapped a $17.5 million Series B round , which the developer says should be enough to cover the tab for its crucial proof-of-concept work. About a year from now the company should have PoC data for both cancer as well as heart failure, CEO Martin Tolar tells FierceBiotech , offering a much clearer picture of the full potential of its development platform. NormOxys is working on a new class of therapeutics-dubbed oxyrens-which essentially restores the needed level of oxygen in diseased “hypoxic tissues.” Anyone familiar with the way heart failure destroys the body can understand the concept in play here.

Read the full story

Floyd Landis: The Isotopes Weren’t Lying, After All

Thursday, May 20th, 2010

This post from 2006 on the science behind Floyd Landis’s suspicious steroid blood tests set my blog record for comments – the debate went on and on about Landis, about the lab that reported the results, about how the samples were handled, etc. Well, Landis has now admitted using performance-enhancing drugs for most of his career.

Read the full story

Of Cambridge, MA Interest Only

Tuesday, April 27th, 2010

Every year there’s a big Cambridge Science Festival , which many companies and institutions around here get involved with.

Read the full story
No Image

Try It At Home

Friday, March 26th, 2010

Technical book author (and occasional commenter here) Robert Bruce Thompson has a channel on YouTube called “The Home Scientist” that’s quite interesting. Many of these seem to be companion videos for his book, The Illustrated Guide to Home Chemistry Experiments . This is real, well-done chemistry with reagents that can be easily purchased and manipulated by a competent non-chemist

Read the full story

A balanced approach to Avandia data

Thursday, February 25th, 2010

-there is not enough evidence to say Actos is any safer than Avandia. – given that there are no head to head studies comparing the two, comparing separate, retrospective studies is not good practice and best avoided (this is precisely what Dr

Posted in: DTC | 0 Comments »
Read the full story